The First Deterministic
Radiographic Analysis
Platform
Where every AI imaging system produces variable outputs depending on model state, RheumaView™ is governed by a multi-stage validator architecture designed to maximize reproducibility for clinical trials and regulated environments.
A comprehensive radiographic interpretation framework — from detection and classification through structured clinical rendering, quantitative research extraction, and cross-modality concordance.
One governed clinical source, controlled renderings, and a separate additive analytic layer.
One validated source. Controlled renderings. Separate analytics.
Crucible™ — a sister platform of RheumaView™. A multi-specialty environment of interactive clinical case-challenges, simulators, and assessment tools authored by a practicing physician, designed for educational, professional-training, and industry-supported contexts across rheumatology, radiology, cardiology, and other medical specialties.
Visit CrucibleWhy Conventional Imaging Analysis Fails
Inter-Reader Variability
Two radiologists reading the same image can disagree on findings, severity, and progression. Clinical trials built on these readings inherit that inconsistency.
Probabilistic Output Drift
AI imaging systems depend on model state, training data, and runtime conditions. The same image processed twice may yield different confidence scores and classifications.
No Structural Audit Trail
Most systems produce a result without showing how it was derived. For regulatory submissions and clinical trial endpoints, this opacity is a fundamental barrier.
How RheumaView™ Is Positioned
Most imaging AI products are designed to detect, triage, or standardize. RheumaView™ is designed to govern the report itself — with a canonical clinical core, deterministic validation, mandatory longitudinal enforcement, and an additive analytics layer that does not rewrite the clinical report.
Enterprise workflow acceleration, triage, and care coordination.
RheumaView is designed around validator-governed MSK/rheumatology reporting with a fixed validation spine and canonical clinical source.
Broad chest X-ray and head CT finding coverage.
RheumaView is specialized for multi-region rheumatology/MSK interpretation, structured to enforce descriptor completeness and longitudinal deltas.
AI second reading for fracture and bone trauma detection.
RheumaView is designed for inflammatory, degenerative, erosive, and composite structural reporting with orphan-prevention rules.
Osteoarthritis classification for knee and hip imaging.
RheumaView is built around a multi-region, multi-date framework with composite integration rules and mandatory delta-based longitudinal interpretation.
Imaging-data standardization, anonymization, and workflow efficiency.
RheumaView is focused on validating the clinical output itself — descriptor completeness, cross-section coherence, and orphan prevention.
AI-enabled image analysis and automated reporting.
RheumaView is built around an immutable clinical core plus a strictly isolated analytics envelope that does not alter clinical sections.
Comprehensive chest X-ray AI with rapid pre-read assistance.
RheumaView is specialized for MSK/rheumatology imaging, designed around quantitative descriptor enforcement and concordance metrics.
Chest X-ray AI for broad CXR interpretation and triage.
RheumaView is differentiated by its architectural separation: READY+ as canonical clinical source, with research outputs strictly additive-only.
Full Platform Comparison
Detailed differentiators and potential value for each platform — with editorial compliance review.
Comparison reflects publicly described product focus and RheumaView's current architecture. It is intended to illustrate product design differences and does not present head-to-head performance, accuracy, clinical outcome, or regulatory superiority claims.
Patent Pending.
Multiple Continuations
in Pipeline.
RheumaView™ is protected by a comprehensive patent portfolio currently under USPTO prosecution, with strategic continuation applications targeting independent inventive domains — each representing a distinct competitive moat.
Multi-stage validator engine, deterministic rendering, quantitative research layer
Multiple continuation applications targeting independent inventive domains across the platform's full capability spectrum
What we've published represents the architectural foundation. The proprietary analytical capabilities — already operational and available to partners — extend far beyond what has been disclosed publicly.
Technical details are protected. The results are available now.
Interested in learning what's below the waterline? We selectively disclose under NDA to qualified partners and investors.
Coverage Across Specialties
Demonstration Domains
Structured distinction between inflammatory, degenerative, and hyperostotic changes (including DISH) based on distribution, morphology, and characteristic features
Longitudinal tracking of disease evolution patterns, identifying whether progression follows inflammatory, degenerative, or mixed trajectories over time
Demonstration domains illustrate the platform's analytical capabilities. All outputs are intended as structured decision support for qualified clinicians and researchers — not as independent diagnostic conclusions.
Not Just About Reading Joints Separately
RheumaView™ maps disease across connected anatomical regions — not as isolated joint-by-joint reads, but as a structured spatial analysis that captures how pathology propagates through functionally related areas.
This is one of the platform's defining capabilities. Read more about the concept and its clinical implications on our research site.
Read Full Article on Research Hub →Disease doesn't respect joint boundaries. RheumaView™ traces structural involvement across anatomical neighborhoods — capturing propagation patterns that isolated reads miss entirely.
A note on disclosure. As our patent prosecution proceeds, we will be gradually and carefully revealing selected unique capabilities of the RheumaView™ platform. Not everything is public yet — and that is by design. Each feature disclosed here has been cleared for public presentation while the full proprietary depth remains protected.
Complex, Cross-Disciplinary Case Analyses
A growing library of multi-specialty radiographic analyses. Each case integrates structural, functional, and quantitative findings across imaging modalities — reflecting the real complexity of clinical practice.
Licensable Clinical Modules for Industry
The Interactive Challenges family contains two physician-authored product lines, built on a shared authorial standard. Both deliver structured clinical content with built-in commercial mechanics — pre-score gate, runtime-configurable banners, completion analytics, and reward / points hand-off — engineered for industry-supported education and CME programs.
Crucible
Multi-stage clinical content — from focused case-challenges to full medical simulators with extended reasoning chains and decision points modeling real-time bedside cognition. Two-, three-, or longer architectures depending on scenario; the v5 engine adds calibration, timing, and per-finding clinical-impact rationale. Live demo gallery is public.
Open Crucible Demo Gallery →Cascade
Structured walkthrough of an advanced therapy: mechanism of action, evidence base, patient selection, practical use, a summative comprehension quiz, and a sponsor reward hand-off. Built on the same authorial standard as Crucible.
Cascade demo cases are not posted publicly. Preview access is granted on request.
Read more about Cascade →Scientific Foundations
RheumaView™ methodology is grounded in a growing body of preprints and manuscripts, published across multiple platforms to establish academic priority and methodological transparency.
Publications span deterministic architecture, cross-modality concordance, clinical trial methodology, and multiple specialized analytical domains. Each paper is crafted to establish priority while preserving proprietary implementation details under patent protection.
What is RheumaView™
RheumaView™ is a deterministic radiographic analysis framework designed for clinical research, pharmaceutical trials, and structured diagnostic support. Unlike probabilistic AI systems, RheumaView™ operates through a validator-governed architecture that produces reproducible, traceable outputs suitable for regulated environments.
Why Deterministic Radiographic Analysis
Radiographic interpretation plays a critical role in musculoskeletal disease research and clinical trials. Variability between readers can affect structural scoring and endpoint reliability. RheumaView™ addresses this challenge through deterministic sequencing and validator-confirmed descriptor generation, ensuring that outputs remain consistent regardless of when or where analysis is performed.
Development
RheumaView™ was developed by an award-winning, multi board-certified rheumatologist with clinical specialization in musculoskeletal imaging and radiographic structural analysis. The framework emphasizes methodological transparency, reproducibility, and compatibility with clinical research workflows.
Patent Status
RheumaView™ is protected under U.S. patent application currently in prosecution via USPTO Track One prioritized examination. Strategic continuation applications targeting additional inventive domains are in pipeline.
Patent Pending · USPTO
How RheumaView™ Is Positioned
Most imaging AI products are designed to detect, triage, or standardize. RheumaView™ is designed to govern the report itself — with a canonical clinical core, deterministic validation, mandatory longitudinal enforcement, and an additive analytics layer that does not rewrite the clinical report.
Public Positioning vs. RheumaView Differentiator
Each entry presents the platform's publicly described focus and how RheumaView is architecturally differentiated.
Enterprise workflow acceleration, triage, and care coordination.
RheumaView is designed around validator-governed MSK/rheumatology reporting with a fixed validation spine and canonical clinical source.
This may matter where users need governed report integrity in high-complexity musculoskeletal reading environments.
Broad chest X-ray and head CT finding coverage.
RheumaView is specialized for multi-region rheumatology/MSK interpretation, structured to enforce descriptor completeness and longitudinal deltas.
This may matter where users need domain-specific structural rigor for specialty reporting.
AI second reading for fracture and bone trauma detection.
RheumaView is designed for inflammatory, degenerative, erosive, and composite structural reporting with orphan-prevention rules.
This may matter where users need disease-pattern reporting and structured progression logic.
Osteoarthritis classification for knee and hip imaging.
RheumaView is built around a multi-region, multi-date framework with composite integration rules and mandatory delta-based longitudinal interpretation.
This may matter where users need enterprise specialty expansion across multiple regions and dates.
Imaging-data standardization, anonymization, and workflow efficiency.
RheumaView is focused on validating the clinical output itself — descriptor completeness, cross-section coherence, and orphan prevention.
This may matter where users need validator-controlled reporting at the clinical output layer.
AI-enabled image analysis and automated reporting.
RheumaView is built around an immutable clinical core plus a strictly isolated analytics envelope that does not alter clinical sections.
This may matter where users need clean clinical deployment today and continuation-ready expansion tomorrow.
Comprehensive chest X-ray AI with rapid pre-read assistance.
RheumaView is specialized for MSK/rheumatology imaging, designed around quantitative descriptor enforcement and concordance metrics.
This may matter where users need MSK-depth specialty-grade consistency and follow-up governance.
Chest X-ray AI for broad CXR interpretation and triage.
RheumaView is differentiated by its architectural separation: READY+ as canonical clinical source, with research outputs strictly additive-only.
This may matter where users need that separation for clinical trust, QA, and layered IP protection.
Full Comparison with Detailed Analysis
The research portal includes expanded differentiators, potential value analysis for each platform, and the complete editorial-compliant comparison.
Comparison reflects publicly described product focus and RheumaView's current architecture. It is intended to illustrate product design differences and does not present head-to-head performance, accuracy, clinical outcome, or regulatory superiority claims.
Scientific Foundations
A growing body of preprints and manuscripts establishing the scientific and methodological foundations of deterministic radiographic analysis. Published across multiple platforms with strategic territorial coverage.
Research Coverage
Publications span multiple independent research domains, each establishing priority claims and methodological foundations.
Deterministic Architecture
Validator-governed systems, execution ordering, lineage preservation
Cross-Modality Concordance
Multi-imaging agreement analysis across X-ray, MRI, CT, DEXA
Clinical Trial Endpoints
Reproducible radiographic scoring for pharmaceutical studies
Explainability & Transparency
Audit trails, visual reasoning, regulatory compliance
Pediatric Normalization
Age-adjusted developmental reference frameworks
Neuro-Structural Mapping
Structure-function correlation methodology
Metabolic & Vascular Analytics
Bone metabolism and microvascular damage frameworks
Secure Data Export
Cryptographic provenance for clinical trial data
Multi-Platform Strategy
Publications are strategically distributed across multiple preprint servers and open-access repositories to maximize visibility, establish territorial claims, and build citation networks across complementary audiences.
All publications are crafted to establish academic priority while preserving proprietary implementation details under patent protection. What we publish demonstrates capability. What we protect enables it.
Complex Cases.
Cross-Disciplinary Analysis.
Reproducible Results.
Selected case illustrations demonstrating deterministic descriptor generation, cross-modality concordance, and reproducible scoring across clinical domains.
Range of Analytical Capabilities
Varied Study Designs
Single-point assessments, longitudinal progression tracking, and serial comparison analyses across different clinical scenarios
Anatomical Scope
Peripheral skeleton, axial skeleton, and combined multi-regional evaluations reflecting the complexity of real clinical presentations
Modality Configurations
Single-modality analyses as well as multi-modality studies with cross-modality concordance where applicable
Reporting Depth
Demonstrations of structured clinical reports, research analytics addendums, and quantitative output formats at varying levels of detail
Cross-Disciplinary Integration
Cases reflecting real clinical complexity, where findings span rheumatology, orthopedics, metabolic, developmental, and neurological domains within single analyses
Additional case illustrations are published on a continuing basis to demonstrate breadth across clinical domains, study configurations, and new research collaborations.
Access the Library
Selected illustrations are publicly available. Comprehensive case analyses and full analytic reports are available to qualified partners upon request.
Who We Work With
RheumaView™ supports clinical trials, research programs, and specialist practices with deterministic radiographic analysis.
Pharmaceutical Companies
Standardized radiographic endpoints for clinical trials. Reproducible structural scoring across study sites with validator-confirmed outputs.
Contract Research Organizations
Deterministic imaging workflows for multi-site trials with validator-confirmed scoring and audit-ready documentation.
Academic Research
Structured radiographic analysis for publications and methodology research with enhanced reproducibility.
Clinical Specialists
Consultation on deterministic radiographic analysis and structured reporting frameworks for musculoskeletal imaging.
Partnership & Access
RheumaView™ collaborations are structured through research partnerships, clinical trial support, and consulting engagements.
Request InformationContact Us
For institutional, research, or partnership discussions, we recommend using the dedicated inquiry page on our research portal — it ensures your message reaches the right team and allows you to include relevant project details.
Professional Inquiries Portal
For collaboration, research support, clinical trial partnerships, and institutional discussions. Includes a structured intake process.
Or contact directly by email